Guilford Acquisition Of Gliatech Has Adcon Coverage Growth In Mind
The number of private payers willing to reimburse for Gliatech's Adcon line of anti-adhesion gels is expected to increase following the firm's merger with Guilford Pharmaceuticals.
The number of private payers willing to reimburse for Gliatech's Adcon line of anti-adhesion gels is expected to increase following the firm's merger with Guilford Pharmaceuticals.